H.R. 3443 · 116th Congress

To clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes.

Stage
In committee
Introduced
2019-06-24
Latest action
2019-07-24 · Sponsor introductory remarks on measure.

Cosponsors (3)